<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05616663</url>
  </required_header>
  <id_info>
    <org_study_id>7954</org_study_id>
    <nct_id>NCT05616663</nct_id>
  </id_info>
  <brief_title>STUDY OF PROFESSIONAL AND INDIVIDUAL FACTORS OF COVID-19 AND IMPACT ON RETURN TO WORK</brief_title>
  <acronym>FP COVID-19</acronym>
  <official_title>SARS-COV-2 INFECTION AMONG HOSPITAL STAFF: STUDY OF PROFESSIONAL AND INDIVIDUAL FACTORS OF COVID-19 AND IMPACT ON RETURN TO WORK</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Started on January 9, 2020 with the announcement of the discovery of a new SARS-CoV-2&#xD;
      coronavirus, the Covid-19 pandemic is responsible as of June 21, 2020 for 160,377 confirmed&#xD;
      cases in France, 29,640 deaths and 9,823 hospitalizations. The Grand Est region is one of the&#xD;
      regions in France that was most precociously and strongly affected by the epidemic, in&#xD;
      particular the Strasbourg University Hospital. Faced with the heavy use of the healthcare&#xD;
      system, hospital staff of all categories are an essential resource to be preserved. Several&#xD;
      studies have shown the significant impact of Covid-19 on doctors and caregivers. In order to&#xD;
      better protect these personnel and avoid contamination that could be harmful to their health&#xD;
      but also because of the consequences in terms of staff, it is necessary to better understand&#xD;
      the risk factors for transmission of this infection, the means of protection, the evolution&#xD;
      of the disease and the determinants of the return to work. Few studies have explored on such&#xD;
      a large workforce and in detail the professional risk factors for developing Covid-19 within&#xD;
      different groups of hospital professionals including also non-caregivers and the evolution&#xD;
      when returning to work in an outpatient population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 31, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective description of the professional and individual characteristics of hospital staff at the Strasbourg University Hospital who presented with a Sars COV-2 infection</measure>
    <time_frame>Files analysed retrospectively from February 01, 2020 to April 15, 2020 will be examined</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">639</enrollment>
  <condition>COVID-19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Professional rom the University Hospitals of Strasbourg (HUS) who had been working at the&#xD;
        HUS at the time of the diagnosis of SARS CoV-2 infection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Major subject (≥18 years old)&#xD;
&#xD;
          -  Professionals from the University Hospitals of Strasbourg (HUS)&#xD;
&#xD;
          -  Professionals who had been working at the HUS at the time of the diagnosis of SARS&#xD;
             CoV-2 infection.&#xD;
&#xD;
          -  Subject having not expressed, after being informed, opposition to the reuse of their&#xD;
             data for research purposes&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - Subject who expressed their opposition to participating in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria GONZALEZ, MD, PhD</last_name>
    <phone>33 3 88 11 64 66</phone>
    <email>maria.gonzalez@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Pathologie Professionnelle et Médecine du Travail - CHU de Strasbourg - France</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria GONZALEZ, MD, PhD</last_name>
      <phone>33 3 88 11 64 66</phone>
      <email>maria.gonzalez@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Maria GONZALEZ, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc-André Goltzene, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariam Roman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique Deiss, Nurs</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Negar Sedghi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence Kling, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique Elbisser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-Claude Greget, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Tchibozo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 14, 2022</study_first_submitted>
  <study_first_submitted_qc>November 14, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2022</study_first_posted>
  <last_update_submitted>November 14, 2022</last_update_submitted>
  <last_update_submitted_qc>November 14, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>SARS-COV-2</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

